当前位置:首页>产品中心>单抗/多抗>Anti-Human TNFA & IL17A Bispecific Reference Antibody|抗人TNFα和IL-17A双特异性参考抗体(靶标:人肿瘤坏死因子α/白细胞介素-17A)

Anti-Human TNFA & IL17A Bispecific Reference Antibody|抗人TNFα和IL-17A双特异性参考抗体(靶标:人肿瘤坏死因子α/白细胞介素-17A)

  • 货号:RB9THS856096
  • 价格:面议
  • 点击:240

产品介绍

产品参数

形态Liquid
宿主种属Human
克隆性Monoclonal
抗体亚型[VH-VH'-H-Gamma1-VL-VL'-C-kappa]-dimer
纯度>95% as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1 mg/ml
内毒素水平Please contact with the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Human
靶标CTLA-8, Cytotoxic T-lymphocyte-associated antigen 8, IL17, IL-17A, IL17A, CTLA8, IL-17, Interleukin-17A, TNF, Tumor necrosis factor ligand superfamily member 2, N-terminal fragment, ICD2, NTF, TNF-a,
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
表达系统Mammalian Cells
登录号Q16552 & P01375
背景信息Remtolumab (ABT-122) is a dual-variable domain immunoglobulin that neutralises both tumor necrosis factor α (TNFα) and IL-17A. Remtolumab shows dual inhibition of TNFα and IL-17A. Remtolumab can be used for rheumatoid arthritis (RA) research.
别名Bispecific, A-1230717, ABT-122, 1791410-27-9
种属Human
备注For research use only. Not suitable for clinical or therapeutic use.
【仅供科学研究使用】

相关产品:
总计 33037 个记录,共 1652 页,当前第 1 页 | 第一页 上一页 下一页 最末页
在线客服
  • 销售热线:
  • 15898894496(同微信)
  • 我要留言
  • 周一至周五每天9:00-17:00